Kristie Paris
Radiation Oncology · Bardstown, KYNPI 1114032505
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.4% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 11.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,170 and has fallen 93.3% since, to $78 in 2023.
Across 123 payments — averaging $18.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$249
- Amgen$213
- Merck$186
- Novartis$170
- Rigel Pharmaceuticals, Inc.$139
- Incyte Corporation$98
- plus $1K from 32 others
What the payments were for
- Food & beverage$2,11394%
- Education$1256%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 10 | $249 |
| Amgen | 11 | $213 |
| Merck | 13 | $186 |
| Novartis | 10 | $170 |
| Rigel Pharmaceuticals, Inc. | 3 | $139 |
| Incyte Corporation | 6 | $98 |
| AstraZeneca(2 entities) | 5 | $89 |
| Bristol Myers Squibb | 4 | $78 |
| Foundation Medicine, Inc. | 2 | $74 |
| Regeneron Healthcare Solutions, Inc. | 4 | $72 |
| Ipsen Biopharmaceuticals, Inc | 3 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $70 |
| Sanofi | 4 | $69 |
| Bayer | 4 | $58 |
| Johnson & Johnson | 4 | $55 |
| Daiichi Sankyo Inc. | 3 | $52 |
| E.r. Squibb & Sons, L.L.C. | 3 | $43 |
| Boehringer Ingelheim | 3 | $41 |
| Clovis Oncology, Inc. | 2 | $36 |
| Verastem, Inc. | 2 | $35 |
| EMD Serono, Inc. | 2 | $33 |
| Lilly USA, LLC | 2 | $30 |
| Jazz Pharmaceuticals Inc. | 2 | $29 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $27 |
| Mirati Therapeutics, Inc. | 1 | $22 |
| Gilead | 1 | $20 |
| Astellas Pharma US Inc | 1 | $18 |
| Array Biopharma Inc | 1 | $18 |
| Tesaro, Inc. | 1 | $17 |
| Acceleron Pharma, Inc. | 1 | $16 |
| GSK | 1 | $16 |
| Dova Pharmaceuticals | 1 | $15 |
| Novocure Inc. | 1 | $15 |
| Pfizer | 1 | $15 |
| AbbVie | 1 | $13 |
| Cumberland Pharmaceuticals, Inc. | 1 | $13 |
| Kyowa Kirin, Inc. | 1 | $13 |
| Puma Biotechnology, Inc. | 1 | $12 |
How this compares
$2,238 in reported general payments places this provider in the 80th percentile of 81 radiation oncology providers in Kentucky.
Other radiation oncology in Bardstown
- Neal DunlapLouisville$98K
- Elyn WangPikeville$21K
- Eddy YangLexington$20K
- Craig SilvermanLouisville$9K
- Shiao WooLouisville$7K
- Ryan AbelOwensboro$6K
- Brian WilliamsLexington$5K
- Justin AndersonLouisville$5K
- Aaron SpaldingLouisville$5K
- Yong ChaLouisville$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.